| Dec 8, 2025 |
Dec 10, 2025 |
Enliven Therapeutics, Inc.
|
COO |
Sell |
41.3
|
-6,663
|
-2.47%
|
✓
|
$140.1K |
| Nov 7, 2025 |
Nov 12, 2025 |
Enliven Therapeutics, Inc.
|
COO |
Sell |
41.3
|
-6,667
|
-2.41%
|
✓
|
$116K |
| Oct 7, 2025 |
Oct 9, 2025 |
Enliven Therapeutics, Inc.
|
COO |
Sell |
41.3
|
-6,667
|
-2.35%
|
✓
|
$134K |
| Sep 8, 2025 |
Sep 10, 2025 |
Enliven Therapeutics, Inc.
|
COO |
Sell |
41.3
|
-6,667
|
-2.30%
|
✓
|
$135K |
| Aug 7, 2025 |
Aug 11, 2025 |
Enliven Therapeutics, Inc.
|
COO |
Sell |
41.3
|
-6,667
|
-2.25%
|
✓
|
$121.6K |
| Jul 7, 2025 |
Jul 9, 2025 |
Enliven Therapeutics, Inc.
|
COO |
Sell |
41.3
|
-6,667
|
-2.20%
|
✓
|
$132K |
| Jun 9, 2025 |
Jun 11, 2025 |
Enliven Therapeutics, Inc.
|
COO |
Sell |
41.3
|
-6,667
|
-2.15%
|
✓
|
$135.6K |
| May 7, 2025 |
May 9, 2025 |
Enliven Therapeutics, Inc.
|
COO |
Sell |
41.3
|
-6,667
|
-2.11%
|
✓
|
$122.6K |
| Apr 7, 2025 |
Apr 9, 2025 |
Enliven Therapeutics, Inc.
|
COO |
Sell |
41.3
|
-6,667
|
-2.06%
|
✓
|
$120.3K |
| Mar 7, 2025 |
Mar 11, 2025 |
Enliven Therapeutics, Inc.
|
COO |
Sell |
41.3
|
-6,667
|
-2.02%
|
✓
|
$142.9K |
| Feb 7, 2025 |
Feb 10, 2025 |
Enliven Therapeutics, Inc.
|
COO |
Sell |
45.0
|
-6,667
|
-1.98%
|
✓
|
$146.2K |
| Jan 7, 2025 |
Jan 10, 2025 |
Enliven Therapeutics, Inc.
|
COO |
Sell |
26.3
|
-28,367
|
-7.77%
|
✓
|
$685.9K |
| Oct 18, 2024 |
Oct 22, 2024 |
Enliven Therapeutics, Inc.
|
COO |
Sell |
53.8
|
-716
|
-0.21%
|
✓
|
$21.5K |
| Jul 12, 2024 |
Jul 16, 2024 |
Enliven Therapeutics, Inc.
|
COO |
Sell |
20.0
|
-50,000
|
-12.69%
|
✓
|
$1.3M |
| Jun 6, 2024 |
Jun 10, 2024 |
Enliven Therapeutics, Inc.
|
COO |
Sell |
52.5
|
-1,133
|
-0.29%
|
✓
|
$22.7K |
| May 14, 2024 |
May 16, 2024 |
Enliven Therapeutics, Inc.
|
COO |
Sell |
52.5
|
-1,107
|
-0.28%
|
✓
|
$27.7K |
| May 9, 2024 |
May 13, 2024 |
Enliven Therapeutics, Inc.
|
COO |
Sell |
56.3
|
-260
|
-0.07%
|
✓
|
$6.5K |
| May 6, 2024 |
May 8, 2024 |
Enliven Therapeutics, Inc.
|
COO |
Sell |
45.0
|
-4,875
|
-1.22%
|
✓
|
$110.8K |
| Apr 11, 2024 |
Apr 15, 2024 |
Enliven Therapeutics, Inc.
|
COO |
Sell |
35.0
|
-17,500
|
-4.25%
|
✓
|
$438.1K |
| Apr 8, 2024 |
Apr 10, 2024 |
Enliven Therapeutics, Inc.
|
COO |
Sell |
45.0
|
-4,875
|
-1.21%
|
✓
|
$90.7K |
| Mar 6, 2024 |
Mar 8, 2024 |
Enliven Therapeutics, Inc.
|
COO |
Sell |
45.0
|
-4,875
|
-1.20%
|
✓
|
$76.2K |
| Feb 6, 2024 |
Feb 8, 2024 |
Enliven Therapeutics, Inc.
|
COO |
Sell |
45.0
|
-4,875
|
-1.19%
|
✓
|
$73.7K |
| Jan 22, 2024 |
Jan 24, 2024 |
Enliven Therapeutics, Inc.
|
COO |
Sell |
45.0
|
-4,875
|
-1.17%
|
✓
|
$73.8K |
| Dec 28, 2023 |
Jan 2, 2024 |
Enliven Therapeutics, Inc.
|
COO |
Sell |
37.5
|
-13,540
|
-3.15%
|
✓
|
$203.3K |
| Dec 22, 2023 |
Dec 27, 2023 |
Enliven Therapeutics, Inc.
|
COO |
Sell |
52.5
|
-1,085
|
-0.25%
|
✓
|
$16.3K |